chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A mammogram is performed and the results showed left axillary lymph nodes with mild cortical thickening
Pain with flexion of muscles in the right shoulder (site of vaccine injection).  This pain with flexion continued for 2-3 months after the vaccination and gradually resolved over that time.  Pain with flexion was noticeable only during strength training exercises involving the right shoulder.  Even today (13 months after vaccination) recurrent pain with flexion occurs in the right shoulder on occasion -- it seems to correlate with nonspecific URI symptoms.  Over the past 13 months since vaccination, I have experienced this pain with flexion 2-3 isolated times.  I think each of these occurrences correlated with nonspecific URI symptoms.
21 hours after receiving the vaccine I experienced body aches and severe fatigue. They lasted for 18 hours. My right arm, where I received the vaccine, was also sore for 3 days.
Patient stated he was feeling dizzy, nauseous and clammy immediately after the injection, 15 minutes after the injection patient was taken back to the examination room - observed for another 15 minutes. Vitals were all good. Evaluated by Dr before being discharged.
no adverse effects reported; two patients received PROQUAD that was improperly stored; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 03-APR-2019, the patient was vaccinated with one improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneously for prophylaxis (dose, lot # and expiration date were not reported). It was unknown whether sterile diluent that was used to reconstitute measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was properly stored. No adverse effects were reported.  Administered dose of vaccine experienced the temperature excursion of minus 13 degrees Celsius for 5 minutes. Data logger was involved. There were no previous excursions reported.   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1904USA004557:
His mother called on July 27, 2007 at 4:55pm and said that her son has had diarrhea since July 26, 2007 a total of 5 times.
Medical assistant calling to report a temperature excursion that occurred 8/14/2020 which involved the following products: GARDASIL9, PEDVAXHIB, RECOMBIVAX, ROTATEQ. Per caller, "it would be possible that at least 100 patients have received vaccines; This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies or concomitant medications were not reported.  On 21-AUG-2020, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally as prophylaxis (lot # 1660991 with expiration date 27-APR-2021) (dose, strength and frequency were not reported).  The improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) experienced a temperature excursion of 35.4 Fahrenheit degrees (°F) for the time frame of 20 minutes without previous temperature excursions. It was confirmed that a digital data logger was involved.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2009USA006106:
Received a Moderna pediatric covid vaccine instead of Moderna Bi-Valent booster. No adverse reaction occured. Rescheduled in 4 weeks to receive a Moderna Bi-Valent Booster.
Muscle twitching, Vertigo a week later, Dizziness for weeks, Treatment: Steroids & Meclizine, I am still experiencing muscle twitching in different parts of my body and it occurs at random moments.
Pain in the arm of injection; Achiness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain in the arm of injection) and MYALGIA (Achiness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Iodine allergy. Concomitant products included AMLODIPINE, HYDROCHLOROTHIAZIDE and ACYCLOVIR [ACICLOVIR] for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain in the arm of injection) and MYALGIA (Achiness). At the time of the report, VACCINATION SITE PAIN (Pain in the arm of injection) and MYALGIA (Achiness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       History relating to mentioned AE and both acute and chronic illnesses at the time of vaccination were reported as no. Other vaccines given within 1 month prior to Moderna COVID-19 vaccine was reported as unknown.  The patient experienced pain in the arm of injection and achiness after every vaccine for a couple of days.  No treatment information were reported.   This case was linked to MOD-2021-030157, MOD-2022-555702 (Patient Link).
This case was reported by a pharmacist via call center representative and described the occurrence of multi-organ failure in a elderly female patient who received FLULAVAL QUADRIVALENT. Co-suspect products included VALTREX unknown for shingles. On an unknown date, the patient received FLULAVAL QUADRIVALENT at an unknown dose. On 17th October 2017, the patient started VALTREX 1000 mg 3 times daily (3000 mg daily). On an unknown date, less than a year after receiving FLULAVAL QUADRIVALENT and VALTREX, the patient experienced multi-organ failure (serious criteria death and GSK medically significant) and shingles. The action taken with VALTREX was unknown. On an unknown date, the outcome of the multi-organ failure was fatal and the outcome of the shingles was unknown. The reported cause of death was multi-organ failure. It was unknown if the reporter considered the multi-organ failure and shingles to be related to FLULAVAL QUADRIVALENT. It was unknown if the reporter considered the multi-organ failure to be related to VALTREX. Additional details were reported as follows: The age at vaccination was not reported. The healthcare professional reported that a patient in a skilled nursing home facility was given FLULAVAL QUADRIVALENT and then developed shingles. The patient started VALTREX and went into multi-organ failure which resulted in her death. The pharmacist did not have information regarding timing of the FLULAVAL QUADRIVALENT dose given and development of shingles. The reporter had no information on batch number or expiration dates of the FLULAVAL QUADRIVALENT. The healthcare professional did not know patient's date of death.
Patient received 2nd Moderna dose at 11am. Within 5 minutes she showed an elevated heart rate of 135 and bp of 148/83.  Her normal blood pressure is 90/50 - and HR in 60s (she is a young, healthy runner) She experienced rigors, anxiety, chills, hypertension, tachycardia,  shortness of breath, chest pressure and chest pain within 15minutes of vaccination and for 45minutes following vaccination. Resolved with symptomatic treatment requiring physician, nurse, respiratory therapist, pharmacist. Patient was given 3.5L of Normal Saline over the course of 1 hour.  100mg of IV Benadryl (50mg at 1055 and 50mg at 1125) 0.5mg of Atrovent via nebulizer at 1124 0.63mg Xopenex via nebulizer at 1124 0.25mg Ativan IVP at 1119 Oxygen At 1141 her BP was 99/56 and HR 110 After 1 hour of treatment she was observed for several hours and recovered from her symptoms. The following day she complained of body aches and headache relieved by ibuprofen.
This is what I added above not realizing there was another space: I am signed up for V-Safe but was so sick I decided to wait and open the each text when I felt better but it turned out they disappear if you don?t complete them right away. So the one foe that day only shows how I feel today, 3 days later. When I?m fact I had 2 extremely PAINFUL days where, thankfully I have pain medication.
I was experiencing very red skin that looked like a bad sunburn. I was very itchy and warm to touch. It affected mostly my face, arms and genitalia. I took a cold shower and some BENADRYL and nothing helped. I did see my general practitioner and he advised it may be an allergy. About a month later I saw an allergist and he did an allergy test. Nothing came back but the control. I also saw a dermatologist and he took biopsies and they came back normal. This redness and itchiness lasted the entire day for about five months. It did end up coming back after a couple weeks. but that time it lasted for about a month then it had subsided and has not come back since.
ON 12/02/2021 PATIENT TOLD ME HE HAD RECENTLY BEEN HOSPITALIZED AND DIAGNOSED WITH GUILLAIN-BARRE SYNDROME AND WAS TOLD THAT IT WAS RELATED TO HIS COVID-19 VACCINE
PT C/O SIGNIFICANT AND SEVERE BILATERAL LEG PAIN SINCE ABOUT 3 DAYS AFTER FIRST MODERNA VACCINE. ONLY OCCURS WITH SIGNIFICANT PHYSICAL ACTIVITY. NO ABNORMALITIES ON EXAM. PT PENDING VASCULAR EVAL ARTERIES AND VEINS OF BLE.
Rash that looks like chickenpox; Slight sore throat; Fever; Fatigue; This case was reported by a other health professional via call center representative and described the occurrence of fatigue in a 51-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th October 2021, the patient received the 1st dose of Shingrix. On 16th October 2021, 4 days after receiving Shingrix, the patient experienced fatigue. On 17th October 2021, the patient experienced fever and sore throat. On 18th October 2021, the patient experienced varicella-like rash. On 20th October 2021, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the fatigue, varicella-like rash and sore throat were not recovered/not resolved.   It was unknown if the reporter considered the fatigue, fever, varicella-like rash and sore throat to be related to Shingrix.  Additional details were provided as follows: The reporter was a physician assistant who reported on behalf of patient. The patient received the Shingrix vaccine and developed fatigue. Five days after vaccination, the patient developed fever and slight sore throat. Six days after vaccination, the patient developed rash that looked like chickenpox. Fever had resolved at the time of reporting.  Fatigue, slight sore throat, and rash were ongoing at the time of reporting. The reporter consented to follow up.
finger and toes are itching and burning right at the top; finger and toes are itching and burning right at the top; a rash at the ends of the finger and toes and both itch.; This spontaneous case was reported by a physician and describes the occurrence of PRURITUS (finger and toes are itching and burning right at the top), BURNING SENSATION (finger and toes are itching and burning right at the top) and RASH PRURITIC (a rash at the ends of the finger and toes and both itch.) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031H21A, 045b21a and 048a21a) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Dec-2021, the patient experienced PRURITUS (finger and toes are itching and burning right at the top), BURNING SENSATION (finger and toes are itching and burning right at the top) and RASH PRURITIC (a rash at the ends of the finger and toes and both itch.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (finger and toes are itching and burning right at the top), BURNING SENSATION (finger and toes are itching and burning right at the top) and RASH PRURITIC (a rash at the ends of the finger and toes and both itch.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.
First extreme tenderness in injection site, several hrs. later upper arm reddened, swelling of upper r arm/bicep area, area became hot/firm & more tender, by am axillary nodes in r arm palpable & tender.  Also temp to 100F x 24hrs. Arm difficult to use because of extreme tenderness with use.
Began to feel feverish, tired, nausea. Redness began to spread over upper arm Wed evening: pain and tightness in upper arm, by Thursday the redness had covered most of upper arm to elbow. The patient saw a NP at his physicians office around 4:00PM Thursday and she prescribed a ZPAK.
Body aches, chills, migraine, fatigue, dizziness, shallow breathing and rash at injection site
Shingles; Red bump on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Red bump on the left arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE MASS (Red bump on the left arm). The patient was treated with VALACYCLOVIR [VALACICLOVIR] for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MASS (Red bump on the left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Patient experienced redness, itching and swelling at injection site which was persisting a few days after vaccination (he was still experiencing on 8/13). As of 8/14 symptoms were almost resolved.
This spontaneous report was received from a medical assistant refers to a patient of an unknown age and gender. The pertinent medical history of the patient was not reported. On 17-OCT-2018, the patient was administered with VARIVAX (lot # R002509, expiration data is 25-JAN-2020)(Dose and frequency are unspecified) subcutaneously for prophylaxis. The unspecified doses of VARIVAX were improperly stored with a temperature of 28 Fahrenheit (F) and storage time less than 1 hour. The temperature excursion occurred as a result of a reading from a digital data logger. There was no occurrence for previous temperature excursion. The concomitant therapy sterile diluent(STERILE DILUENT)(lot#M015992, expiration date is 26-NOV-2018) was not reported to be improperly stored by the reporter. No adverse effects were reported. The outcome of events was unknown. This Is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1901USA001564: US-009507513-1901USA001565:
Local rxn characterized by hot, hard; Upper other thigh swollen to knee; child screaming; Onset a few hrs post inject;
Hive, 3cm x 2cm erythema with small central flare noted about 5 minutes after MMR vaccine given in (L) thigh. Hive located about 1cm above injection site. No other hives noted. No other.
Headache; Joint ache; Muscle ache; Warmth, swelling, & redness at injection site, which remains, but improving.; Warmth, swelling, & redness at injection site, which remains, but improving.; Warmth, swelling, & redness at injection site, which remains, but improving.; This is a spontaneous report from a non-contactable consumer (patient herself). This is first of two reports.  A 66-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: ER8729, Expiry date was not reported), via an unspecified route of administration, administered in Arm Right on 07Apr2021 19:45 (Age at vaccination 66-years-old) as dose 2, single for covid-19 immunization. The patient was not pregnant at time of vaccination. Medical history included Known allergies sulfa , factor v leiden carrier from an unknown date and unknown if ongoing Leiden Factor V. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included warfarin, ascorbic acid (VITAMIN C [ASCORBIC ACID]), colecalciferol (VITAMIN D3), vitamin b complex (VITAMIN B [VITAMIN B COMPLEX]), diphenhydramine taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took pseudoephedrine and experienced drug allergy, first dose of bnt162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: ER8729, Expiry date was not reported), via an unspecified route of administration, administered in Arm Right on 17Mar2021 (Age at vaccination 66-years-old) as dose 1, single for covid-19 immunization and experienced myalgia, arthralgia, headache. On 08Apr2021 at 02:00, the patient experienced head, joint and muscle aches worse than first injection, very painful for first 24 hours then slowly diminished and almost gone, about 65 hours later. The patient also experienced warmth, swelling and redness at injection site which remained, but was improving. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Patient states rib pain, soreness at site redness measure on Left arm 9x6cm, Headaches, difficulty breathing, joint stiffness and dizziness Right leg feels numb and imbalance.
24 hours (about 3:30pm Wednesday, Sept 18) after receiving the injection, I started having a slight headache, stiffness and soreness in my neck and arms.  Later that same evening I had a high fever (100) and my body was very warm.  While my body was warm, I was freezing and cold.  I took two Tylenol. I retired around 9:00pm and during the night the fever broke and I produced a lot of sweat.  By the next morning, Thursday. I was weak and still a little stiff.  I took two more Tylenol and around noon on Thursday I was feeling normal.  Since that event I have had no more symptoms.
Patient stated that her right hand started itching and turned red at 12pm after receiving the vaccine at 11:40am.
Approx 20 min after vaccination patient developed itching at the site and this progressed to include chest, neck. EMS evaluated patient who recommended transport and patient agreed. Benadryl offered by EMS and IV started. Pt with concurrent treatment for valley fever noted.   ED administered medications - famotidine 20mg iv, methylprednisolone 125mg iv, NS 1000ml bolus. Prescribed prednisone 20mg po daily x 2 days.
pain in arm; chaffing armpit and feels uncomfortable; chaffing armpit and feels uncomfortable; rash under his armpit; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), SKIN IRRITATION (chaffing armpit and feels uncomfortable), DISCOMFORT (chaffing armpit and feels uncomfortable), RASH (rash under his armpit) and VACCINATION SITE PAIN (pain at injection site) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in arm), SKIN IRRITATION (chaffing armpit and feels uncomfortable), DISCOMFORT (chaffing armpit and feels uncomfortable), RASH (rash under his armpit) and VACCINATION SITE PAIN (pain at injection site). At the time of the report, PAIN IN EXTREMITY (pain in arm), SKIN IRRITATION (chaffing armpit and feels uncomfortable), DISCOMFORT (chaffing armpit and feels uncomfortable), RASH (rash under his armpit) and VACCINATION SITE PAIN (pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  Treatment medication included a cream.
This spontaneous report as received from a register nurse refers to a 78 year old female patient. The patient's pertinent medical history included hypothyroidism, primary pulmonary hypertension, atrial fibrillation, benign essential hypertension, severe rheumatoid arthritis and osteoporosis. It was also reported that the patient had a history of allergy to amlodipine and AUGMENTIN. On an unspecified date in 2006, the patient was vaccinated with PNEUMOVAX 23 (dose, route of administration, lot # and expiration date were not provided). The nurse reported that the patient took many unspecified medications. On an unspecified date, the patient developed pneumonia. The patient was diagnosed on 12-JAN-2015. The patient received ZITHROMAX as a treatment of adverse event and chest x-ray was performed. The patient sought medical attention. The outcome of the event was reported as recovering/resolving. The relatedness between the event and the PNEUMOVAX 23 was not provided. Additional information has been requested.
Gave the paitent an MMRV  and Varicella instead of an MMR and Varicella.
per patient, after she received the vaccine she developed SOB and chest pain. She said it resolved in about 2 days. she notified her pcp.
Mom reported posterior right arm, 1 1/2 inch diameter, red, hard and itchy after receiving vaccines 7-15-09.  Onset of symptoms; 7/16/09.  Still with small redness today.  Reports having no pain.